PGDx elio tissue complete CDx
FDA-approved hybrid-capture NGS companion diagnostic on FFPE tumor tissue; current CDx scope includes melanoma BRAF V600E/V600K.
- Developer
- PGDx
- Intended use
- Other
- Cancer scope
- Not reported
- Specimen
- FFPE tumor tissue
- Molecular modality
- DNA mutation
- Current version
- PGDx elio tissue complete CDx P250036
- Evidence context
- 1 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.